title: Handling sirolimus in clinical practice. Spanish Nephrology Society.
authors.affiliation: Servicio de Nefrología, Hospital Clinic, Barcelona. oppenhei@medicina.ub.es
authors.forename: F
authors.initials: F
authors.lastname: Oppenheimer
authors.forename: A
authors.initials: A
authors.lastname: Alonso
authors.forename: M
authors.initials: M
authors.lastname: Arias
authors.forename: J M
authors.initials: JM
authors.lastname: Campistol
authors.forename: M
authors.initials: M
authors.lastname: González Molina
authors.forename: J M
authors.initials: JM
authors.lastname: González Posada
authors.forename: J M
authors.initials: JM
authors.lastname: Grinyo
authors.forename: J M
authors.initials: JM
authors.lastname: Morales
authors.forename: A
authors.initials: A
authors.lastname: Sánchez Fructuoso
authors.forename: J
authors.initials: J
authors.lastname: Sánchez-Plumed
authors.forename: J C
authors.initials: JC
authors.lastname: Ruiz
mesh_terms: D000014:Abnormalities, Drug-Induced; D000818:Animals; D002986:Clinical Trials as Topic; D004353:Drug Evaluation, Preclinical; D004347:Drug Interactions; D004359:Drug Therapy, Combination; D005260:Female; D006084:Graft Rejection / Q000517:prevention & control; D006086:Graft vs Host Disease / Q000517:prevention & control; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D008297:Male; D015337:Multicenter Studies as Topic; D016377:Organ Transplantation; D011183:Postoperative Complications / Q000139:chemically induced* / Q000188:drug therapy / Q000517:prevention & control; D011247:Pregnancy; D011248:Pregnancy Complications / Q000139:chemically induced; D020123:Sirolimus / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*
chemical_list: D007166:Immunosuppressive Agents; D020123:Sirolimus